Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng(The University of Texas MD Anderson Cancer Center), Guangchun Han(The University of Texas MD Anderson Cancer Center), Nahum Puebla‐Osorio(The University of Texas MD Anderson Cancer Center), Man Chun John(The University of Texas MD Anderson Cancer Center), Paolo Strati(The University of Texas MD Anderson Cancer Center), Beth Chasen(The University of Texas MD Anderson Cancer Center), Enyu Dai(The University of Texas MD Anderson Cancer Center), Minghao Dang(The University of Texas MD Anderson Cancer Center), Neeraj Jain(The University of Texas MD Anderson Cancer Center), Haopeng Yang(The University of Texas MD Anderson Cancer Center), Yuanxin Wang(The University of Texas MD Anderson Cancer Center), Shaojun Zhang(The University of Texas MD Anderson Cancer Center), Ruiping Wang(The University of Texas MD Anderson Cancer Center), Runzhe Chen(The University of Texas MD Anderson Cancer Center), Jordan Showell(The University of Texas MD Anderson Cancer Center), Sreejoyee Ghosh(The University of Texas MD Anderson Cancer Center), Sridevi Patchva(The University of Texas MD Anderson Cancer Center), Qi Zhang(The University of Texas MD Anderson Cancer Center), Ryan Sun(The University of Texas MD Anderson Cancer Center), Frederick Hagemeister(The University of Texas MD Anderson Cancer Center), Luis Fayad(The University of Texas MD Anderson Cancer Center), Felipe Samaniego(The University of Texas MD Anderson Cancer Center), Hans C. Lee(The University of Texas MD Anderson Cancer Center), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), Nathan Fowler(The University of Texas MD Anderson Cancer Center), R. Eric Davis(The University of Texas MD Anderson Cancer Center), Jason R. Westin(The University of Texas MD Anderson Cancer Center), Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Linghua Wang(The University of Texas MD Anderson Cancer Center), Michael R. Green(The University of Texas MD Anderson Cancer Center)
Cited by 591Open Access
Abstract
Related Papers
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data